Fifth Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day Makes History as the Biggest Day EverPRNewsWire • 11/20/23
Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder PatientsBusiness Wire • 11/20/23
Up To 16% Dividend Growth And Yields Reaching 6%: November's Top 10 Dividend Growth StocksSeeking Alpha • 11/18/23
Results Published in The Lancet Show UBRELVY® (ubrogepant) Reduces the Headache Phase of a Migraine Attack When Dosed During the Prodrome of MigrainePRNewsWire • 11/16/23
AbbVie and Pfizer Have 1 Thing in Common: Their Biggest Products Are on the Decline. Time to Sell?The Motley Fool • 11/16/23
My Dividend Stock Portfolio: New October Dividend Record - 98 Holdings With 23 BuysSeeking Alpha • 11/15/23
Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next‑Generation Lithium Therapeutic Drug Candidate AL001Business Wire • 11/13/23
AbbVie's $21 Billion Drug Humira Is on the Decline. Should You Still Buy This Dividend Stock?The Motley Fool • 11/10/23
Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold ForeverThe Motley Fool • 11/04/23